News

Krystal Biotech, Inc. ((KRYS)) has held its Q2 earnings call. Read on for the main highlights of the call. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock ...
Q2 2025 Management View CEO Krish S. Krishnan highlighted that "the VYJUVEK launch...is progressing well, and the upcoming launches in Europe and Japan are expected to significantly add to what is ...
Krystal Biotech Inc (KRYS) reports robust earnings with $96 million in net VYJUVEK revenue and plans for European and ...